$Zepp Health (ZEPP.US)$ Severely undervalued...waiting for September...there will be a small climax from the September new product release until the end of the year.

$Zepp Health (ZEPP.US)$ After the fourth-quarter financial report, zepp has achieved positive net profits for two consecutive quarters, reaching a balanced profit development. The market has given negative feedback on the decline in sales. Zepp's stock price dropped by more than $1, entering a strong buy phase.